For this purpose, melanoma cell lines bearing a defined BRAF mutation (A375 BRAF-V600E) were treated with the small molecule BRAF inhibitor Dabrafenib (GSK2118436) until developing resistance. The gene discussed is BRAF; the disease is melanoma.